SE461502B - Komposition foer reglerad frisaettning av ett vattenloesligt laekemedel fraan en mikrofasseparerad hydrogel - Google Patents

Komposition foer reglerad frisaettning av ett vattenloesligt laekemedel fraan en mikrofasseparerad hydrogel

Info

Publication number: SE461502B
Authority: SE; Sweden
Prior art keywords: water; weight; copolymer; soluble; mixture
Prior art date: 1983-09-15

Application number

SE8404568A

Other languages

English (en)

Swedish (sv)

Other versions

SE8404568L (sv

SE8404568D0 (sv

Inventor

K R Shah

Original Assignee

Kendall & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-15

Filing date

1984-09-12

Publication date

1990-02-26

1984-09-12 Application filed by Kendall & Co filed Critical Kendall & Co

1984-09-12 Publication of SE8404568D0 publication Critical patent/SE8404568D0/xx

1985-03-16 Publication of SE8404568L publication Critical patent/SE8404568L/xx

1990-02-26 Publication of SE461502B publication Critical patent/SE461502B/sv

Links

239000000203 mixture Substances 0.000 title claims description 62
239000000017 hydrogel Substances 0.000 title description 2
230000001105 regulatory effect Effects 0.000 title description 2
229920001577 copolymer Polymers 0.000 claims description 54
239000000178 monomer Substances 0.000 claims description 25
JYGXADMDTFJGBT-VWUMJDOOSA-N Hydrocortisone Natural products O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 23
229940079593 drug Drugs 0.000 claims description 20
239000003814 drug Substances 0.000 claims description 20
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 17
229960000890 hydrocortisone Drugs 0.000 claims description 12
SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims description 10
229920001519 homopolymer Polymers 0.000 claims description 9
229960003387 progesterone Drugs 0.000 claims description 9
239000000186 progesterone Substances 0.000 claims description 9
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 8
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 7
230000002209 hydrophobic effect Effects 0.000 claims description 6
229920002554 vinyl polymer Polymers 0.000 claims description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 5
FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 5
229940088644 n,n-dimethylacrylamide Drugs 0.000 claims description 4
YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 3
229920003169 water-soluble polymer Polymers 0.000 claims description 3
125000000017 cortisol group Chemical group 0.000 claims 1
239000000499 gel Substances 0.000 description 33
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
239000013543 active substance Substances 0.000 description 12
239000000126 substance Substances 0.000 description 11
239000003795 chemical substances by application Substances 0.000 description 10
229920000642 polymer Polymers 0.000 description 10
238000013270 controlled release Methods 0.000 description 9
239000011159 matrix material Substances 0.000 description 7
229920002959 polymer blend Polymers 0.000 description 7
150000003431 steroids Chemical class 0.000 description 6
230000002378 acidificating effect Effects 0.000 description 5
210000004379 membrane Anatomy 0.000 description 5
239000012528 membrane Substances 0.000 description 5
238000005192 partition Methods 0.000 description 5
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 4
-1 polyethylene Polymers 0.000 description 4
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
239000003433 contraceptive agent Substances 0.000 description 3
238000013267 controlled drug release Methods 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 2
OLQFXOWPTQTLDP-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCOCCO OLQFXOWPTQTLDP-UHFFFAOYSA-N 0.000 description 2
XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
MZGMQAMKOBOIDR-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCO MZGMQAMKOBOIDR-UHFFFAOYSA-N 0.000 description 2
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
239000004599 antimicrobial Substances 0.000 description 2
230000002051 biphasic effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
229960003276 erythromycin Drugs 0.000 description 2
125000005670 ethenylalkyl group Chemical group 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
239000003205 fragrance Substances 0.000 description 2
239000000417 fungicide Substances 0.000 description 2
QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
239000002917 insecticide Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
239000004014 plasticizer Substances 0.000 description 2
229940126585 therapeutic drug Drugs 0.000 description 2
ORKBYCQJWQBPFG-WOMZHKBXSA-N (8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;(8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 ORKBYCQJWQBPFG-WOMZHKBXSA-N 0.000 description 1
HQGPZXPTJWUDQR-UHFFFAOYSA-N 1-ethenyl-5-methylpyrrolidin-2-one Chemical compound CC1CCC(=O)N1C=C HQGPZXPTJWUDQR-UHFFFAOYSA-N 0.000 description 1
PBGPBHYPCGDFEZ-UHFFFAOYSA-N 1-ethenylpiperidin-2-one Chemical compound C=CN1CCCCC1=O PBGPBHYPCGDFEZ-UHFFFAOYSA-N 0.000 description 1
GSSDUXHQPXODCN-UHFFFAOYSA-N 1-phenylethenylphosphonic acid Chemical compound OP(O)(=O)C(=C)C1=CC=CC=C1 GSSDUXHQPXODCN-UHFFFAOYSA-N 0.000 description 1
DAVVKEZTUOGEAK-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound COCCOCCOC(=O)C(C)=C DAVVKEZTUOGEAK-UHFFFAOYSA-N 0.000 description 1
PRAMZQXXPOLCIY-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethanesulfonic acid Chemical compound CC(=C)C(=O)OCCS(O)(=O)=O PRAMZQXXPOLCIY-UHFFFAOYSA-N 0.000 description 1
OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
YXYJVFYWCLAXHO-UHFFFAOYSA-N 2-methoxyethyl 2-methylprop-2-enoate Chemical compound COCCOC(=O)C(C)=C YXYJVFYWCLAXHO-UHFFFAOYSA-N 0.000 description 1
GAVHQOUUSHBDAA-UHFFFAOYSA-N 3-butyl-1-ethenylaziridin-2-one Chemical compound CCCCC1N(C=C)C1=O GAVHQOUUSHBDAA-UHFFFAOYSA-N 0.000 description 1
GKGOIYMLPJJVQI-UHFFFAOYSA-N 4-ethenylbenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(C=C)C=C1 GKGOIYMLPJJVQI-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
240000002024 Gossypium herbaceum Species 0.000 description 1
235000004341 Gossypium herbaceum Nutrition 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
239000000006 Nitroglycerin Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000011149 active material Substances 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000003732 agents acting on the eye Substances 0.000 description 1
125000005250 alkyl acrylate group Chemical group 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229940088623 biologically active substance Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000000748 compression moulding Methods 0.000 description 1
229940124558 contraceptive agent Drugs 0.000 description 1
230000002254 contraceptive effect Effects 0.000 description 1
239000000599 controlled substance Substances 0.000 description 1
229920006037 cross link polymer Polymers 0.000 description 1
LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
208000002925 dental caries Diseases 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
150000002222 fluorine compounds Chemical class 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
229960003711 glyceryl trinitrate Drugs 0.000 description 1
229930000755 gossypol Natural products 0.000 description 1
229950005277 gossypol Drugs 0.000 description 1
229920000578 graft copolymer Polymers 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
229920001600 hydrophobic polymer Polymers 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
229940023490 ophthalmic product Drugs 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920000233 poly(alkylene oxides) Polymers 0.000 description 1
229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
229920000867 polyelectrolyte Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
150000008442 polyphenolic compounds Chemical class 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
125000000542 sulfonic acid group Chemical group 0.000 description 1
FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
238000000870 ultraviolet spectroscopy Methods 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
- C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Compositions Of Macromolecular Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE8404568A 1983-09-15 1984-09-12 Komposition foer reglerad frisaettning av ett vattenloesligt laekemedel fraan en mikrofasseparerad hydrogel SE461502B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53264383A	1983-09-15	1983-09-15
US06/606,794 US4693887A (en)	1983-09-15	1984-05-03	Microphase separated hydrogels for controlled release of bioactive materials

Publications (3)

Publication Number	Publication Date
SE8404568D0 SE8404568D0 (sv)	1984-09-12
SE8404568L SE8404568L (sv)	1985-03-16
SE461502B true SE461502B (sv)	1990-02-26

Family

ID=27063895

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8404568A SE461502B (sv)	1983-09-15	1984-09-12	Komposition foer reglerad frisaettning av ett vattenloesligt laekemedel fraan en mikrofasseparerad hydrogel

Country Status (18)

Country	Link
US (1)	US4693887A (fr)
AT (1)	ATA290884A (fr)
AU (1)	AU577056B2 (fr)
BE (1)	BE900581A (fr)
BR (1)	BR8404409A (fr)
CA (1)	CA1232201A (fr)
CH (1)	CH666415A5 (fr)
DE (1)	DE3432573A1 (fr)
DK (1)	DK410984A (fr)
ES (1)	ES8607357A1 (fr)
FR (1)	FR2551976B1 (fr)
GB (2)	GB2147002B (fr)
IT (1)	IT1178430B (fr)
NL (1)	NL8402833A (fr)
NO (1)	NO843650L (fr)
NZ (1)	NZ209323A (fr)
PT (1)	PT79192B (fr)
SE (1)	SE461502B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2576213B1 (fr) *	1985-01-21	1989-02-24	Cortial	Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US4883669A (en) *	1985-02-25	1989-11-28	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3517080A1 (de) *	1985-05-11	1986-11-13	Bayer Ag, 5090 Leverkusen	Komponente fuer therapeutische wirkstoffabgabesysteme
IE59361B1 (en) *	1986-01-24	1994-02-09	Akzo Nv	Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
US4971790A (en) *	1986-02-07	1990-11-20	Alza Corporation	Dosage form for lessening irritation of mocusa
US4867969A (en) *	1986-02-07	1989-09-19	Alza Corporation	Hydrogel formulation for administering non-steroidal drugs
JPS62223112A (ja) *	1986-03-25	1987-10-01	Rooto Seiyaku Kk	歯周病治療剤
DE3617158C2 (de) *	1986-05-22	1994-10-06	Lohmann Therapie Syst Lts	Transdermales Arzneimittel
US5145682A (en) *	1986-05-30	1992-09-08	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4965253A (en) *	1987-10-14	1990-10-23	University Of Florida	Viscoelastic material for ophthalmic surgery
US5656286A (en)	1988-03-04	1997-08-12	Noven Pharmaceuticals, Inc.	Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) *	1988-03-04	1995-12-12	Noven Pharmaceuticals, Inc.	Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5133992A (en) *	1988-03-21	1992-07-28	Eastman Kodak Company	Colloidally stabilized suspension process
US4931287A (en) *	1988-06-14	1990-06-05	University Of Utah	Heterogeneous interpenetrating polymer networks for the controlled release of drugs
EP0347145A3 (fr) *	1988-06-14	1990-10-24	University Of Utah Research Foundation	Réseaux polymères hétérogènes interpénétrants pour la libération commandée de substances pharmaceutiques
US5073381A (en) *	1988-08-15	1991-12-17	University Of Akron	Amphiphilic networks
US5270358A (en) *	1989-12-28	1993-12-14	Minnesota Mining And Manufacturing Company	Composite of a disperesed gel in an adhesive matrix
ES2062900B1 (es) *	1991-07-29	1995-07-01	Univ Madrid Nac Educacion	Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.
DK0616505T3 (fr) *	1991-11-15	1997-02-24	Minnesota Mining & Mfg
US5352448A (en) *	1992-07-20	1994-10-04	Purdue Research Foundatioin	Oral administration of antigens
DE69310887T2 (de) *	1992-07-29	1998-01-22	Baxter Int	Pharmazeutische behälter und medizinische geräte mit hydrophilen, proteinverträglichen oberflächen
DE4341156C2 (de) *	1993-12-02	1997-11-13	Wacker Chemie Gmbh	Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5840338A (en) *	1994-07-18	1998-11-24	Roos; Eric J.	Loading of biologically active solutes into polymer gels
US5603955A (en) *	1994-07-18	1997-02-18	University Of Cincinnati	Enhanced loading of solutes into polymer gels
DE19622355A1 (de) *	1996-06-04	1997-12-11	Bayer Ag	Formkörper die agrochemische Mittel freisetzen
DE19629468A1 (de) *	1996-07-11	1998-01-15	Schering Ag	Transdermale therapeutische Systeme
US8003705B2 (en)	1996-09-23	2011-08-23	Incept Llc	Biocompatible hydrogels made with small molecule precursors
US5814329A (en) *	1996-11-12	1998-09-29	Polytherapeutics, Inc.	Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
DE19753298A1 (de) *	1997-12-01	1999-06-02	Basf Ag	Verfahren zur Herstellung von festen Dosierungsformen
US20020188037A1 (en) *	1999-04-15	2002-12-12	Chudzik Stephen J.	Method and system for providing bioactive agent release coating
WO1999055396A1 (fr)	1998-04-27	1999-11-04	Surmodics, Inc.	Revetement destine a liberer des agents bioactifs
US6632457B1 (en) *	1998-08-14	2003-10-14	Incept Llc	Composite hydrogel drug delivery systems
JP2002531217A (ja)	1998-12-04	2002-09-24	チャンドラシェカーピー．パサック，	生体適合性架橋ポリマー
CN1272071C (zh)	2002-03-14	2006-08-30	美德阿利克斯株式会社	创伤用外用剂
US7097850B2 (en)	2002-06-18	2006-08-29	Surmodics, Inc.	Bioactive agent release coating and controlled humidity method
US20040111144A1 (en) *	2002-12-06	2004-06-10	Lawin Laurie R.	Barriers for polymeric coatings
WO2005003192A1 (fr) *	2003-06-26	2005-01-13	Symyx Technologies, Inc.	Synthese de polymeres photosensibles
WO2005027864A1 (fr) *	2003-09-19	2005-03-31	Symyx Technologies, Inc.	Materiaux conçus pour une meilleure administration d'agents actifs hydrophiles dans des preparations de soins personnels
JP2007532187A (ja)	2004-04-06	2007-11-15	サーモディクス，インコーポレイティド	生物活性物質のためのコーティング組成物
WO2007035954A2 (fr) *	2005-09-23	2007-03-29	Duramed Pharmaceuticals, Inc.	Comprimes vaginaux comportant du misoprostol et leurs procedes de fabrication et d'utilisation
MX2008010126A (es) *	2006-02-08	2010-02-22	Tyrx Pharma Inc	Protesis de malla temporalmente rigidizadas.
AU2008214319A1 (en) *	2007-02-06	2008-08-14	Incept, Llc	Polymerization with precipitation of proteins for elution in physiological solution
CN201075472Y (zh) *	2007-05-28	2008-06-18	富士康(昆山)电脑接插件有限公司	电连接器
US9125807B2 (en)	2007-07-09	2015-09-08	Incept Llc	Adhesive hydrogels for ophthalmic drug delivery
US8745133B2 (en) *	2008-03-28	2014-06-03	Yahoo! Inc.	System and method for optimizing the storage of data
JP5890182B2 (ja) *	2009-02-12	2016-03-22	インセプトエルエルシー	ヒドロゲルプラグによる薬物送達
US8961501B2 (en)	2010-09-17	2015-02-24	Incept, Llc	Method for applying flowable hydrogels to a cornea
US10226417B2 (en)	2011-09-16	2019-03-12	Peter Jarrett	Drug delivery systems and applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4085168A (en) *	1971-02-22	1978-04-18	Cpc International Inc.	Chemically joined, phase separated self-cured hydrophilic thermoplastic graft copolymers and their preparation
US4277582A (en) *	1978-03-03	1981-07-07	Ciba-Geigy Corporation	Water-insoluble hydrophilic copolymers
SU806037A1 (ru) *	1978-04-06	1981-02-23	Всесоюзный Кардиологический Научныйцентр Amh Cccp	Антиангинальное средство
SU1243627A3 (ru) *	1979-12-05	1986-07-07	Дзе Кендалл Компани (Фирма)	Гелеобразующа композици
SE448544B (sv) *	1979-12-05	1987-03-02	Kendall & Co	Vattenabsorberande komposition och anvendning derav som berare for ett lekemedel
US4259314A (en) *	1979-12-10	1981-03-31	Hans Lowey	Method and composition for the preparation of controlled long-acting pharmaceuticals
US4423099A (en) *	1980-07-28	1983-12-27	Ciba-Geigy Corporation	Membrane modified hydrogels
JPS5776046A (en) *	1980-10-27	1982-05-12	Kendall & Co	Water absorbing composition

1984
- 1984-05-03 US US06/606,794 patent/US4693887A/en not_active Expired - Fee Related
- 1984-08-22 AU AU32268/84A patent/AU577056B2/en not_active Ceased
- 1984-08-23 NZ NZ209323A patent/NZ209323A/en unknown
- 1984-08-28 DK DK410984A patent/DK410984A/da not_active Application Discontinuation
- 1984-09-04 BR BR8404409A patent/BR8404409A/pt unknown
- 1984-09-05 DE DE19843432573 patent/DE3432573A1/de not_active Withdrawn
- 1984-09-10 FR FR8413866A patent/FR2551976B1/fr not_active Expired
- 1984-09-11 PT PT79192A patent/PT79192B/pt not_active IP Right Cessation
- 1984-09-11 AT AT842908A patent/ATA290884A/de not_active Application Discontinuation
- 1984-09-12 SE SE8404568A patent/SE461502B/sv not_active IP Right Cessation
- 1984-09-13 IT IT8448836A patent/IT1178430B/it active
- 1984-09-14 BE BE0/213653A patent/BE900581A/fr not_active IP Right Cessation
- 1984-09-14 NL NL8402833A patent/NL8402833A/nl not_active Application Discontinuation
- 1984-09-14 ES ES535923A patent/ES8607357A1/es not_active Expired
- 1984-09-14 CH CH4417/84A patent/CH666415A5/de not_active IP Right Cessation
- 1984-09-14 NO NO843650A patent/NO843650L/no unknown
- 1984-09-14 CA CA000463168A patent/CA1232201A/fr not_active Expired
- 1984-09-17 GB GB08423416A patent/GB2147002B/en not_active Expired
1986
- 1986-08-19 GB GB08620117A patent/GB2177708A/en not_active Withdrawn

Also Published As

Publication number	Publication date
GB8423416D0 (en)	1984-10-24
US4693887A (en)	1987-09-15
GB2147002B (en)	1987-11-11
CH666415A5 (de)	1988-07-29
GB2147002A (en)	1985-05-01
IT1178430B (it)	1987-09-09
FR2551976A1 (fr)	1985-03-22
CA1232201A (fr)	1988-02-02
AU3226884A (en)	1985-03-21
BE900581A (fr)	1985-03-14
NZ209323A (en)	1987-04-30
GB8620117D0 (en)	1986-10-01
IT8448836A0 (it)	1984-09-13
FR2551976B1 (fr)	1988-06-10
DK410984A (da)	1985-03-16
AU577056B2 (en)	1988-09-15
NO843650L (no)	1985-03-18
BR8404409A (pt)	1985-07-30
PT79192A (en)	1984-10-01
NL8402833A (nl)	1985-04-01
PT79192B (en)	1986-08-14
ES8607357A1 (es)	1986-05-16
SE8404568L (sv)	1985-03-16
SE8404568D0 (sv)	1984-09-12
ES535923A0 (es)	1986-05-16
DE3432573A1 (de)	1985-04-18
ATA290884A (de)	1991-07-15
IT8448836A1 (it)	1986-03-13
GB2177708A (en)	1987-01-28
DK410984D0 (da)	1984-08-28

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 8404568-1

Effective date: 19930406

Format of ref document f/p: F

Publication	Publication Date	Title
SE461502B (sv)	1990-02-26	Komposition foer reglerad frisaettning av ett vattenloesligt laekemedel fraan en mikrofasseparerad hydrogel
US4591496A (en)	1986-05-27	Process for making systems for the controlled release of macromolecules
Bhatt et al.	2021	Polymers in drug delivery: an update
Brannon-Peppas et al.	1989	Solute and penetrant diffusion in swellable polymers. IX. The mechanisms of drug release from pH-sensitive swelling-controlled systems
Zhang et al.	2002	A novel thermo-responsive drug delivery system with positive controlled release
Graham et al.	1984	Hydrogels for controlled drug delivery
Yoshida et al.	1989	A new temperature-sensitive hydrogel with α-amino acid group as side chain of polymer
EP0163696B1 (fr)	1992-11-25	Application d'une bioadhesive
Mandal	2000	Swelling-controlled release system for the vaginal delivery of miconazole
EP1077678B1 (fr)	2010-12-29	Compositions mucoadhesives pour l'application d'agents biologiquement actifs a des tissus animaux
CA1078734A (fr)	1980-06-03	Implant de surfactif a liberation progressive
Zalfen et al.	2008	Controlled release of drugs from multi-component biomaterials
Graham et al.	2018	Polymeric inserts and implants for the controlled release of drugs
DE2528068A1 (de)	1976-01-08	Wasserunloesliche hydrophile copolymere
US10653783B2 (en)	2020-05-19	Sustained release of bioactive factors from zwitterionic hydrogels
O’Neill	2019	Membrane systems
US5352455A (en)	1994-10-04	Controlled release compositions
DE3685869T2 (de)	1992-12-24	Formulierung mit verzoegerter wirkstoffabgabe, die ein hydrophobes polymersystem enthaelt.
Tarawneh et al.	2023	Development of mucoadhesive cellulose derivatives based films for the treatment of vaginal candidiasis
JP3227462B2 (ja)	2001-11-12	均一ヒドロゲルコポリマーの製法
US20100178315A1 (en)	2010-07-15	Polymeric systems for controlled drug therapy
JPS60100513A (ja)	1985-06-04	生物活性物質を調節して開放するための微小相の分離されたヒドロゲル
US4145408A (en)	1979-03-20	Controlled release article
JPH0640890A (ja)	1994-02-15	徐放性製剤
Tekin et al.	1990	Swelling of PHEMA based membranes in ethanol and their nitroglycerin permeabilities